Drugs / Tears Naturale
Tears Naturale
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07657858 | Jan → Jul 2026 overdue | cataract, dry eye syndrome | Jin Yang | Recruiting | No outcome recorded |
| — | NCT06720428 | Jan 2021 → May 2024 | dry eye syndrome | Shanghai 10th People's Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01072526 Comparator | Dec 2007 → Aug 2010 | dry eye syndrome | University of Missouri-Columbia | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05425914 Background | Nov 2021 → Mar 2022 | dry eye syndrome, vitamin D deficiency | University of Faisalabad | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05314621 Comparator | Dec 2021 → Jul 2022 | conjunctivitis | Andover Research Eye Institute | Completed | No outcome recorded |
| Phase 4 | NCT05265910 Comparator | Dec 2021 → Apr 2022 | conjunctivitis | Andover Research Eye Institute | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07185854 Background | Jan 2024 → Jun 2025 | dry eye syndrome | Nadide Koca | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tears Naturale | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05314621 ↗ |
| Known as | Artificial tear | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06720428 ↗ |
| Known as | Artificial tears | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07185854 ↗ |
| Known as | Euphrasia-based homeopathic therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01072526 ↗ |
| Known as | Sodium Hyaluronate Eye Drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07657858 ↗ |
| Modality | Other / unclassified | “Euphrasia-based homeopathic therapy” NCT01072526 ↗ |
| Route | Other | “ophthalmic solution” NCT01072526 ↗ |